Logo image
Sign in
Xanomeline-Trospium as a Novel Agent for Treatment of Psychosis in Schizophrenia
Journal article   Peer reviewed

Xanomeline-Trospium as a Novel Agent for Treatment of Psychosis in Schizophrenia

Caitlin Leconte, Albert Dickan, Haley Schuster, Mark Mullen and Rajesh R. Tampi
The Psychiatric times, Vol.42(2), p.16
02/01/2025

Abstract

Drug therapy Schizophrenia Trospium

Metrics

1 Record Views

Details

Logo image